P38-MAP-KINASE-INHIBITOREN

European patent · EP2350049 · In force

Register entry

Publication number
EP2350049
Application number
EP09785724
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 2, 2009
Published
Aug 3, 2011
Granted
Feb 26, 2014
Protection ends at the latest
Oct 1, 2029
Next annual fee due
Oct 31, 2026
IPC classes
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
A61K 31/415 (2006.01)
A61P 11/00 (2006.01)
A61P 29/00 (2006.01)
Priority
GB 0818033 02.10.2008
GB 0822609 11.12.2008
PCT application
PCT/GB2009/051304 02.10.2009
PCT publication
WO2010/038086 08.04.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Feb 26, 2014

    Granted

    Published in Swissreg on 26.02.2014

Parties

Holder

Respivert Limited

50-100 Holmers Farm Way, High Wycombe Buckinghamshire HP12 4EG, GB

Inventor

ITO, Kazuhiro

London SW7 2AZ, GB

STRONG, Peter

London SW7 2AZ, GB

RAPEPORT, William, Garth

London SW7 2AZ, GB

MURRAY, Peter, John

London SW7 2AZ, GB

KING-UNDERWOOD, John

Worcestershire GL19 3PW, GB

WILLIAMS, Jonathan, Gareth

Nottingham NG1 1GF, GB

ONIONS, Stuart ,Thomas

Nottingham NG1 1GF, GB

HIRST, Simon, Christopher

Nottingham NG1 1GF, GB

TADDEI, David, Michel, Adrien

Nottingham NG1 1GF, GB

CHARRON, Catherine, Elizabeth

London SW7 2AZ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.